Dr. Jejo D. Koola, MD

Dr. Koola practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Koola's NPI, 1073775532, was assigned on June 26, 2008. Dr. Koola graduated from Medical University of South Carolina (MUSC) in 2008. Dr. Koola holds California license A122014.

Dr. Koola's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Koola's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Koola is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koola practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Koola's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Koola is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Koola's licenses on file in 7 states: California, Tennessee, Texas, New Mexico, South Carolina, Virginia and Washington.

Dmand AI lists pneumonia and respiratory infection and sepsis among the conditions Dr. Koola treats.

CMS data shows 150 Medicare services from Dr. Koola across 4 procedure codes in 2024, for 68 Medicare patients. Medicare paid $9,907 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Koola in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koola's median patient age at 59, with 52% women.

In 2024, Dr. Koola wrote 44 Medicare Part D claims for 14 patients. 86% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $204 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Koola for performance year 2024, reported as part of a group. Dr. Koola accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Koola, published from 2007 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Transcranial Magnetic Stimulation, Algorithms and Electromyography. Dr. Koola has published most often in J ECT. Dr. Koola's most frequent co-authors are Michael E. Matheny, MD, MPH, MS, Stuart L. Goldstein, MD and Frank Andrew Kozel, MD.

Dmand AI lists 2 awards for Dr. Koola, most recently Distinguished Poster in 2016.

Dr. Koola graduated from Medical University of South Carolina (MUSC) in 2008.

Dr. Koola is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.